Labrina Barmpetaki, President of PIF: “Harnessing medical data is essential for a fair and sustainable pharmaceutical policy.” Through targeted interventions and a clear, strategic message, PhARMA Innovation Forum (PIF) actively participated in the 6th Health Conference organized by Proto Thema. Labrina Barmpetaki, joined the panel discussion entitled “Shaping a National Pharmaceutical Policy: Prerequisites and Challenges.”…
Labrina Barmpetaki, President of PIF: “Innovation is the future of pharmaceutical policy.” Pharmaceutical innovation took center stage at the 10th Delphi Economic Forum, with Pharma Innovation Forum (PIF) participating in the panel titled “Safeguarding Innovation, Fueling Growth and Social Prosperity.” Representatives from the Goverment and the pharmaceutical industry — including the Minister of Health Mr.…
Labrina Barmpetaki, President of PIF: “The patient cannot wait. Access to the right treatment, at the right time, must be our common goal.” PhARMA Innovation Forum Greece highlights the value of innovation in health, aiming at the immediate implementation of solutions to address cancer challenges at the 9th ELLOK Conference PhARMA Innovation Forum…
Pharma Innovation Forum Greece highlights the value of innovation at the National Congress of the Hellenic Association of Health Economics. Pharma Innovation Forum (PIF) and its members continue to lead the public dialogue on health, focusing on promoting pharmaceutical innovation as a pillar of sustainability and equitable access to innovative treatments. The General Secretary of…
Letter from PIF & AMCHAM Pharma Committee to the Prime Minister: Dear Prime Minister, At this particularly critical juncture for the pharmaceutical industry, we address you as the Board of Directors of PhARMA Innovation Forum (PIF) and the Committee of Pharmaceutical Companies of the American-Hellenic Chamber of Commerce, to express our deep concern about…
Fewer than 2 out of 10 treatments are covered by the state, severely limiting patients’ access to innovative and critical therapies. Following the meeting between the Minister of Health, Mr. Adonis Georgiadis, and the pharmaceutical industry associations, the issue of mandatory clawback payments for the first half of 2023 is being hastily addressed, with the…
A new Board of Directors was elected by the General Assembly of the members of PhARMA Innovation Forum (PIF) Greece, held yesterday. The new Board came together earlier today for the first time to assign internal roles and responsibilities. As a result of this procedure, Labrina Barmpetaki, President & Managing Director, Abbvie Pharmaceuticals Greece, Cyprus…
Innovation plays a key role in all areas of human activity. However, its contribution to the health sector, especially after the COVID-19 pandemic, is now indisputable. As the General Manager of PhARMA Innovation Forum Greece, Mariangela Ekonomopoulou, tells NEWS247: «The enormous positive impact of innovation on people’s lives is additionally attested by the increase in…
The debate on the contribution of the private health sector to society, the national economy and entrepreneurship is an excellent occasion not so much to record the multiple benefits coming from this contribution, but mainly to start a meaningful dialogue around its limits, i.e. around the required balance between the private and public sectors in…
Τhe series of closed working sessions within the framework of the “Meeting Patients’ Needs” initiative, recently announced by the PhARMA Innovation Forum Greece continued with Hematology. At the center of the discussion were the particularities of the journey of the patients of the specific therapeutic category and their needs regarding both access to their treatments…
